Evidence map›Paper›PMID 41309774›Full record

ArticleScientific reports2025

Prognostic value of stromal CD39

Hai-Yan Sun, Shan Kang, Jian-Lei Wu, Xue-Ping Li, Yue-Ping Liu, Yan Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hai-Yan SunDepartment of Obstetrics and Gynaecology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China.
Shan KangDepartment of Obstetrics and Gynaecology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China. ksjq62cn@sina.com.
Jian-Lei WuDepartment of Obstetrics and Gynaecology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China.
Xue-Ping LiDepartment of Obstetrics and Gynaecology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China.
Yue-Ping LiuDepartment of Pathology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China.
Yan LiDepartment of Molecular Biology, Fourth Hospital, Hebei Medical University, Jiankanglu 12, Shijiazhuang, 050011, China. yanli_doctor1962@163.com.

Funding

Hebei Provincial Health and Family Planning Commission 20200099Natural Science Foundation of Hebei Province H2020206385
6 · The paper itself

Abstract

This study aimed to investigate the expression levels of CD8

Indexed as

ApyraseCarcinoma, Ovarian EpithelialCD8-Positive T-LymphocytesOvarian NeoplasmsPlatinumAdultAgedBiomarkers, TumorDrug Resistance, NeoplasmFemaleHumansLymphocytes, Tumor-InfiltratingMiddle AgedNomogramsPrognosisStromal CellsApyraseBiomarkers, TumorENTPD1 protein, humanPlatinumCD39+CD8+ t cellsEpithelial ovarian cancerNomogramPlatinum-based chemotherapyPrognosisTumor microenvironment

Identifiers

PMID41309774
PMCPMC12660849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.